Final Answer:
If a patient receiving corticosteroids for type I hypersensitivity (allergy) develops increased blood glucose levels, the nurse should promptly report this finding to the healthcare provider, as it may indicate hyperglycemia.
Step-by-step explanation:
Which finding associated with use of corticosteroids as collaborative treatment for type I hypersensitivity (allergy) will the nurse report to the patient's health care provider?If a patient receiving corticosteroids as collaborative treatment for type I hypersensitivity (allergy) experiences increased blood glucose levels, the nurse should promptly report this finding to the patient's healthcare provider.
Corticosteroids can cause hyperglycemia as a side effect by promoting gluconeogenesis and impairing glucose utilization. In individuals with diabetes or those predisposed to glucose metabolism abnormalities, this can lead to elevated blood sugar levels. It is crucial to monitor and manage blood glucose levels in patients receiving corticosteroids, especially if they have pre-existing diabetes.
Prompt communication with the healthcare provider allows for appropriate adjustments in the treatment plan and consideration of alternative medications or interventions.